The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASH.L Regulatory News (ASH)

  • There is currently no data for ASH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed CVA and potential Reverse Takeover

30 Jul 2020 12:25

RNS Number : 6429U
Ashley House PLC
30 July 2020
 

Ashley House plc

 

Proposed Company Voluntary Arrangement and potential Reverse Takeover

 

Ashley House plc ("Ashley House" or the "Company") announces that it has filed a Company Voluntary Arrangement ("CVA") proposal and is in discussions for the Company to potentially combine with Piper Homes plc ("Piper"), an unlisted Midland based housing developer, by way of a Reverse Takeover or similar transaction.

Background

On 6 March 2020, the Company announced that, due to the material uncertainty of the Company's current financial condition, trading in the Company's shares on both AIM and NEX was suspended from that date. Trading in the Company's shares on NEX was withdrawn on 26 March 2020.

Since that date, the Company has explored many options to raise further funding and corporate opportunities to meet its ongoing working capital commitments and to support its affordable housing strategy. This included the administration of the Company's 76% subsidiary, F1 Modular Limited, as announced on 30 March 2020 and the sale of its interests in Partnering Health Limited and Infracare LIFT Holdings Limited as announced on 7 May 2020.

Despite its best efforts, the Company has been unable to raise further funds with the COVID-19 pandemic seriously restricting the Company's ability to do so.

For the last two months, the Company has been discussing a potential transaction with Piper. The discussions have been wide ranging but have included, amongst other structures, whether Piper could potentially obtain a listing through a Reverse Takeover of the Company pursuant to AIM Rule 14 or another similar transaction (the "Proposed Transaction").

Company Voluntary Arrangement

In order to allow the Company to pursue a future corporate strategy and avoid administration or liquidation and to achieve the best result possible from the current position for creditors, shareholders and other stakeholders, the Board believes that it is in the best interests of the Company to enter into the following arrangements:

· Documentation has been filed in the High Court and will today be dispatched to the creditors of the Company, together with a notice convening a Creditors' Meeting, the purpose of which is to consider the Directors' proposal for a CVA, subject to shareholder approval;

· The Company has engaged Begbies Traynor (Central) LLP to act as Nominee and Supervisor for the CVA;

· Piper Homes plc has paid £50,000 to Ashley House to fund the initial costs of pursuing the proposals, with a further £50,000 payable once the CVA has been approved and the 28 day challenge period has passed; and

· The Company is issuing today a Circular to shareholders ("Circular") setting out the background to the CVA and seeking shareholders' approval for it. Notice convening a General Meeting to be held on 18 August 2020, to consider and, if thought fit, approve a Resolution giving this approval, is set out at the end of the Circular.

The CVA will not result in any distribution being made to existing members in their capacity as shareholders.

Based upon discussions to date, shareholders should be aware that, in any Proposed Transaction, the value attributable to the equity in Ashley House is likely to be minimal, albeit it is anticipated that shareholders would have some further opportunity to participate in the enlarged group through a subscription warrant structure. Further details will be provided in due course.

Any Proposed Transaction with Piper is conditional upon:

(i) the approval of the CVA both by shareholders and by the Company's creditors; and

(ii) the passing in due course at a General Meeting of resolutions to approve the Proposed Transaction, the grant of authority to allot new shares in connection with such transaction and waiver by the Takeover Panel of the mandatory offer requirement which would otherwise arise from such allotment.

If either of the above conditions are not satisfied, then the Proposed Transaction will not proceed and, since the Company would have insufficient working capital to continue to trade, the Directors would likely have no alternative but to place the Company immediately into administration or liquidation. There can be no certainty that the Proposed Transaction will proceed or as to the terms of any Proposed Transaction.

Report and Accounts Update

The Company's reporting deadline for the publication of its annual audited accounts for the period ended 31 October 2019 has been extended to 31 July 2020 as a result of the COVID-19 pandemic. The Company will not now be in a position to publish its accounts by this date. The results for the eighteen month period to 31 October 2019 will show a significant loss.

As stated above, the shares of the Company were suspended from trading on AIM on 6 March 2020 as a result of material financial uncertainty. In order to complete the Proposed Transaction, the Company would need to seek from the London Stock Exchange permission to extend beyond 6 September 2020 the period during which its shares remain suspended and should it do so, such permission may or may not be forthcoming. However, the Company and Piper in any case continue to explore alternative means to deliver a similar commercial outcome and will update shareholders in due course.

The Company again thanks its lenders, creditors, shareholders and all stakeholders for their continued patience and support in this difficult time.

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Not for release, publication or distribution, in whole or in part, directly or indirectly in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

 

Enquiries:

Ashley House plc 01628 600 340

Antony Walters

Jonathan Holmes

James Hathaway

 

WH Ireland 0207 220 1666

(Nominated Adviser and Broker)

Adrian Hadden

James Sinclair-Ford

Darshan Patel

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAFXEDAAEEFA
Date   Source Headline
16th Feb 20117:00 amRNSResponse to Result of AH Medical EGM
9th Feb 20115:47 pmRNSInterim Report and Accounts
26th Jan 20118:31 amRNSDirector Dealings
25th Jan 20117:00 amRNSInterim Results
19th Jan 20117:01 amRNSResponse to Offer by Assura Group for AH Medical
19th Jan 20117:00 amPRNRecommended Offer by Assura Group for AH Medical
29th Dec 20107:00 amRNSProperty Funding and Trading Update
18th Oct 201011:27 amRNSCompletion of Acquisition
5th Oct 201010:04 amRNSHolding(s) in Company
4th Oct 20105:15 pmRNSHolding(s) in Company
27th Sep 20104:38 pmRNSResult of AGM
27th Sep 20107:00 amRNSBusiness Update
24th Aug 20105:41 pmRNSForm 8.3 - AH Medical Properties plc
10th Aug 20109:17 amRNSHolding(s) in Company
13th Jul 201012:11 pmRNSDividend Declaration
13th Jul 20107:00 amRNSBoard Appointment
9th Jul 20105:05 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
9th Jul 20104:25 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
6th Jul 20109:59 amRNSHolding(s) in Company
6th Jul 20107:00 amRNSPreliminary results
21st May 20105:41 pmRNSHolding(s) in Company
4th May 201012:21 pmRNSForm 8.3 - AH Medical Properties plc
4th May 20107:00 amRNSTrading Update and Acquisition
22nd Feb 20103:09 pmRNSDirectorate Change
15th Feb 20107:00 amRNSProgress Update
27th Jan 20105:37 pmRNSDividend Declaration
26th Jan 20107:00 amRNSInterim Results
16th Dec 20091:42 pmRNSWarrent extension
9th Dec 20099:51 amRNSHolding(s) in Company
2nd Dec 20095:03 pmRNSHolding(s) in Company
23rd Nov 20095:06 pmRNSDirectorate Change
20th Nov 20094:00 pmRNSAcquisition
16th Nov 200912:48 pmRNSTrading Update
5th Oct 20093:38 pmRNSHolding(s) in Company
1st Oct 20095:50 pmRNSDirector/PDMR Shareholding
30th Sep 20092:24 pmRNSResult of AGM
1st Sep 200911:53 amRNSPosting of circular
14th Aug 20097:00 amRNSIssue of Equity
7th Aug 20092:49 pmRNSDividend Declaration
3rd Aug 20098:59 amRNSHolding(s) in Company
6th Jul 20097:00 amRNSPreliminary Results
17th Jun 20092:59 pmRNSTrading Update
8th Jun 20094:33 pmRNSHolding(s) in Company
2nd Jun 20093:26 pmRNSDirector Change
14th May 20095:14 pmRNSHolding(s) in Company
13th May 20095:34 pmRNSHolding(s) in Company
7th May 20094:05 pmRNSHolding(s) in Company
7th May 20094:03 pmRNSHolding(s) in Company
30th Apr 20094:07 pmRNSPlacing of B&B Stake
29th Apr 200911:44 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.